Angiogenic growth factors inhibit chondrocyte ageing in osteoarthritis: Potential involvement of catabolic stress-induced overexpression of caveolin-1 in cellular ageing

International Journal of Rheumatic Diseases

Volumn 12, Issue 2, 2009, Pages 90-99

  Yudoh, Kazuo ^a   Shi, Yeqing ^a,b   Karasawa, Rie ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Ageing; Angiogenic growth factor; Caveolin 1; Chondrocyte

Indexed keywords

ANGIOGENIC GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CAVEOLIN 1; GROWTH FACTOR; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE INHIBITOR; SCATTER FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL AGING; CELL DIVISION; CELL ISOLATION; CELL STRESS; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KNEE ARTHROPLASTY; LIFESPAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CAVEOLIN 1; CELL AGING; CELLS, CULTURED; CHONDROCYTES; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTOR 2; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1BETA; MAP KINASE SIGNALING SYSTEM; OSTEOARTHRITIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; STRESS, PHYSIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67749086596     PISSN: 17561841     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2009.01390.x     Document Type: Article

References (51)

1. Martin JA, Buckwalter JA (2002) Human chondrocyte senescence and osteoarthritis. Biorheology 39, 145-52.
2. Martin JA, Buckwalter JA (2003) The role of chondrocyte senescence in the pathogenesis of osteoarthritis and in limiting cartilage repair. J Bone Joint Surg Am: 85-A (suppl. 2), 106-10.
3. Price JS, Waters JG, Darrah C, et al. (2002) The role of chondrocyte senescence in osteoarthritis. Aging Cell 1, 57-65.
4. Martin JA, Buckwalter JA (2001) Roles of articular cartilage aging and chondrocyte senescence in the pathogenesis of osteoarthritis. Iowa Orthop J 21, 1-7.
5. Aigner T, Kurz B, Fukui N, Sandell L (2002) Roles of chondrocytes in the pathogenesis of osteoarthritis. Curr Opin Rheumatol 14, 578-84.
6. Martin JA, Ellerbroek SM, Buckwalter JA (1997) Age-related decline in chondrocyte response to insulin-like growth factor-1: The role of growth factor binding proteins. J Orthop Res 15, 491-8.
7. Volonte D, Zhang K, Lisanti MP, Galbiati F (2002) Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. Mol Biol Cell 277, 41295-8.
8. Cho KA, Park SC (2005) Caveolin-1 as a prime modulator of aging: A new modality for phenotypic restoration? Mech Ageing Dev 126, 105-10.
9. Fujimoto T, Kogo H, Nomura R, Une T (2000) Isoforms of caveolin-1 and caveolae structure. J Cell Sci 113, 3509-17.
10. Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, Lisanti MP (1995) Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J Biol Chem 270, 15781-5.
11. Liu PS, Michael R, Richard GWA (2002) Multiple functions of caveolin-1. J Biol Chem 277, 41295-8.
12. Smart EJ, Graf GA, McNiven MA, et al. (1999) Caveolin, liquid-ordered domains, and signal transduction. Mol Cell Biol 19, 7289-304.
13. Kurzchalia TV, Parton RG (1999) Membrane microdomains and caveolae. Curr Opin Cell Biol 11, 424-31.
14. Schwab W, Kasper M, Gavlik JM, Schulze E, Funk RH, Shakibaei M (2000) Characterization of caveolins from human knee joint cartilage: expression of caveolin-1-2, and -3 in chondrocytes and association with integrin beta 1. Histochem Cell Biol 113, 221-5.
15. Schwab W, Galbiati F, Volonte D, et al. (1999) Characterisation of caveolins from cartilage. expression of caveolin-1-2 and -3 in chondrocytes and in alginate cell culture of the rat tibia. Histochem Cell Biol 112, 41-9.
16. Dai SM, Shan ZZ, Nakamura H, et al. (2006) Catabolic stress induces features of chondrocyte senescence through overexpression of caveolin-1: Possible involvement of caveolin-1-induced down-regulation of articular chondrocytes in the pathogenesis of osteoarthritis. Arthritis Rheum 54, 818-31.
17. Cho KA, Ryu SJ, Park JS, et.al. SC (2003) Senescent phenotype can be reversed by reduction of caveolin status. J Bio Chem 278, 27789-95.
18. Galbiati F, Volonte D, Engelman JA, et al. (1998) Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17, 6633-48.
19. Liu J, Wang XB, Park DS, Lisanti MP (2002) Caveolin-1 expression enhances endothelial capillary tubule formation. J Biol Chem 277, 10661-8.
20. Regina A, Jodoin J, Khoueir P, et al. (2004) Down-regulation of caveolin-1 in glioma vasculature: Modulation by radiotherapy. J Neurosci Res 75, 291-9.
21. Yeo EJ, Park SC (2002) Age-dependent agonist-specific dysregulation of membrane-mediated signal transduction: Emergence of the gate theory of aging. Mech Ageing Dev 123, 1563-78.
22. Park WY, Park JS, Cho KA, et al. (2000) Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells. J Biol Chem 275, 20847-52.
23. Taipale J, Keski-Oja J (1997) Growth factors in the extracellular matrix. FASEB 11, 51-9.
24. Pfander D, Kortje D, Zimmermann R, et al. (2001) Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann Rheum Dis 60, 1070-3.
25. Enomoto H, Inoki I, Komiya K, et al. (2003) Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol 162, 171-81.
26. Powers CJ, Mcleskey SW, Wellstein A (2000) Fibroblast growth factors, their receptors and signaling. Endocrine-Related Cancer 7, 165-97.
27. Pfander D, Cramer T, Weseloh G, et al. (1999) Hepatocyte growth factor in human osteoarthritic cartilage. Osteoarthritis Cartilage 7, 548-59.
28. Maskazu N, Jun H, Ko K, et.al. (2001) Hepatocyte growth factor (HGF), HGF activator, and C-Met in synovial tissues in rheumatoid arthritis and osteoarthritis. J Rheum 28, 1772-8.
29. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5, 623-8.
30. Cuevas P, Burgos J, Baird A (1988) Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. Biochem Biophys Res Commun 156, 611-8.
31. Wakitani S, Imoto K, Kimura T, Ochi T, Matsumoto K, Nakamura T (1997) Hepatocyte growth factor facilitates cartilage repair: Full thickness articular cartilage defect studied in rabbit knees. Acta Orthop Scand 68, 474-80.
32. Reboul P, Pelletier JP, Tardif G, et al. (2001) Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: Involvement of the stress-activated protein kinase/C-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade. Arthritis Rheum 44, 73-84.
33. Liu J, Babak R, Tang SQ, et al. (1999) Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1. J Biol Chem 274, 15781-5.
34. Squires GR, Okouneff A, Lonescu M, Pool AR (2003) The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Arthritis Rheum 48, 1261-70.
35. Stanton LA, Underhill TM, Beier F (2003) MAP kinases in chondrocyte differentiation. Dev Biol 263, 165-75.
36. Hommes DW, Peppelenbosch MP, Van Deventer SJH (2003) Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52, 144-51.
37. Fox T, Coll JT, Xie XL, et al. (1998) A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase. Protein Sci 7, 2249-55.
38. Krasilnikov MA (2000) Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation. Biochemistry 65, 68-78.
39. Orna H, Lewis C (2004) Differential regulation of the phosphoinositid 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells. Exp Cell Res 297, 224-34.
40. Engelman JA, Chu C, Lin A, et al. (1998) Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 428, 205-11.
41. Galbiati F, Volonte D, Engelman JA, et al. (1998) Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase casade. EMBO J 17, 6633-48.
42. Jeffrey AE, Zhang XL, Babak R, Richard GP, Michael PL (1999) p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. J Biol Chem 274, 32333-41.
43. Volonte D, Liu Y, Galbiati F (2005) The modulation of caveolin-1 expression controls satellite cell activation during muscle repair. FASEB J 19, 237-9.
44. Fujita Y, Maruyama S, Kogo H, Matsue S, Fujimoto T (2004) Caveolin-1 in mesangial cells suppresses MAP kinase activation and cell proliferation induced by bFGF and PDGF. Kidney Int 66, 1794 -804.
45. Krajewska WM, Maslowska I (2004) Caveolins. structure and function in signal transduction. Cell Mol Biol Lett 9, 195-220.
46. Lentasch S, Chatterjee M, Gries M, et al. (2004) PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells. Leukemia 18, 1883-90.
47. Shi YH, Wang YX, Bingle L, et al. (2005) In vitro study of HIF activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions involvement of PI3K/Akt and Mek1/ERK pathways. J Pathol 205, 530-6.
48. Riera MF, Meroni SB, Pellizzari EH, Cigorraga SB (2003) Assessment of the roles of mitogen-activated protein kinase and phosphatidyl inositol 3-kinase/protein kinase B pathways in the basic fibroblast growth factor regulation of Sertoli cell function. J Mol Endocrinol 31, 279-89.
49. Thompson J, Dolcet X, Hilton M, Tolcos M, Davies AM (2004) HGF promotes survival and growth of maturing sympathetic neurons by PI3 kinase- and MAP kinase-dependent mechanisms. Mol Cell Neurosci 27, 441-52.
50. Yoo SA, Yoon HJ, Kim HS, et al. (2009) Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: A link between angiogenesis and inflammation. Arthritis Rheum 60, 345-54.
51. Yoo SA, Kwok SK, Kim WU (2008) Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention. Mediators Inflamm 2008, 129873. Epub 2009 Feb 10.